Oral nanotherapeutics based on Antheraea pernyi silk fibroin for synergistic treatment of ulcerative colitis
- PMID: 35202934
- DOI: 10.1016/j.biomaterials.2022.121410
Oral nanotherapeutics based on Antheraea pernyi silk fibroin for synergistic treatment of ulcerative colitis
Abstract
Ulcerative colitis (UC) with its rapidly increasing incidence has become an emerging challenge for public health. Therapeutic agents are required to be specifically delivered to colon epithelial cells and macrophages with controlled release in the cytoplasm for wound healing, inflammation alleviation, and microbiota rebalance. As a promising biomaterial for accomplishing this, Antheraea pernyi silk fibroin (ApSF) was selected and engineered to form nanoparticles (NPs) loaded with the anti-inflammatory drug, resveratrol (Res). The intrinsic features of these fabricated Res-ApNPs included targeting of colonic epithelial cells and macrophages, lysosomal escape capacity, and responsiveness to pH, reactive oxygen species (ROS), and glutathione, which were pertinent to their functional units such as arginine-glycine-aspartate tripeptides, α-helixes, β-sheets, and disulfide bonds, enabling on-demand release of Res molecules in the cytoplasm of target cells. The Res-ApNP treatment restored damaged colonic epithelial barriers, polarized macrophages to type M2, alleviated inflammatory reactions, and reduced the level of intracellular ROS. Oral treatment with chitosan-alginate hydrogels embedded with Res-ApNPs substantially relieved UC symptoms, as evidenced by decreased colonic inflammation, increased synthesis of tight-junction proteins, and rebalanced intestinal microbiota. Our findings suggest that these high-performance ApSF-based NPs can be developed as effective drug carriers for oral UC treatment.
Keywords: Antheraea pernyi silk Fibroin; Anti-inflammation; Microbiota modulation; Ulcerative colitis; Wound healing.
Copyright © 2022 Elsevier Ltd. All rights reserved.
Similar articles
-
Multi-bioresponsive silk fibroin-based nanoparticles with on-demand cytoplasmic drug release capacity for CD44-targeted alleviation of ulcerative colitis.Biomaterials. 2019 Aug;212:39-54. doi: 10.1016/j.biomaterials.2019.05.012. Epub 2019 May 9. Biomaterials. 2019. PMID: 31103945
-
Mucus-Penetrating Silk Fibroin-Based Nanotherapeutics for Efficient Treatment of Ulcerative Colitis.Biomolecules. 2022 Sep 8;12(9):1263. doi: 10.3390/biom12091263. Biomolecules. 2022. PMID: 36139101 Free PMC article.
-
Ion-induced fabrication of silk fibroin nanoparticles from Chinese oak tasar Antheraea pernyi.Int J Biol Macromol. 2015 Aug;79:316-25. doi: 10.1016/j.ijbiomac.2015.04.052. Epub 2015 Apr 30. Int J Biol Macromol. 2015. PMID: 25936281
-
Silk fibroin-based nanotherapeutics: application in the treatment of colonic diseases.Nanomedicine (Lond). 2019 Sep;14(17):2373-2378. doi: 10.2217/nnm-2019-0058. Epub 2019 Jul 10. Nanomedicine (Lond). 2019. PMID: 31290366 Free PMC article. Review.
-
Chinese Oak Tasar Silkworm Antheraea pernyi Silk Proteins: Current Strategies and Future Perspectives for Biomedical Applications.Macromol Biosci. 2019 Mar;19(3):e1800252. doi: 10.1002/mabi.201800252. Epub 2018 Oct 8. Macromol Biosci. 2019. PMID: 30294916 Review.
Cited by
-
Nanotechnology's frontier in combatting infectious and inflammatory diseases: prevention and treatment.Signal Transduct Target Ther. 2024 Feb 21;9(1):34. doi: 10.1038/s41392-024-01745-z. Signal Transduct Target Ther. 2024. PMID: 38378653 Free PMC article. Review.
-
Layer by layer self-assembled hyaluronic acid nanoarmor for the treatment of ulcerative colitis.J Nanobiotechnology. 2024 Oct 18;22(1):633. doi: 10.1186/s12951-024-02933-3. J Nanobiotechnology. 2024. PMID: 39420343 Free PMC article.
-
Optimizing the Preparation of Silk Fibroin Nanoparticles and Their Loading with Polyphenols: Towards a More Efficient Anti-Inflammatory Effect on Macrophages.Pharmaceutics. 2023 Jan 12;15(1):263. doi: 10.3390/pharmaceutics15010263. Pharmaceutics. 2023. PMID: 36678894 Free PMC article.
-
Gas-propelled nanomotors alleviate colitis through the regulation of intestinal immunoenvironment-hematopexis-microbiota circuits.Acta Pharm Sin B. 2024 Jun;14(6):2732-2747. doi: 10.1016/j.apsb.2024.02.008. Epub 2024 Feb 12. Acta Pharm Sin B. 2024. PMID: 38828144 Free PMC article.
-
Oral Cell-Targeted Delivery Systems Constructed of Edible Materials: Advantages and Challenges.Molecules. 2022 Nov 17;27(22):7991. doi: 10.3390/molecules27227991. Molecules. 2022. PMID: 36432092 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials